Riot Platforms Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Riot Platforms Inc trades at $16.83 (market cap $6.32B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.54 (market cap $2.27B). The key difference: Riot Platforms Inc is far larger — about 2.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals.
| RIOT | SLS | |
|---|---|---|
Market Cap | $6.32B | $2.27B |
Volume | 30,571,756 | 4,179,659 |
Sector | Financials | Health |
52-Week High | $28.67 | $15.46 |
52-Week Low | $11.83 | $1.39 |
Typical Hold Time | 16 Days | — |
Enterprise Value | $6.73B | $2.14B |
Signals from Pluang's Aura AI — not financial advice
RIOT stock trades at $16.69, down 9.98% with bearish technical signals despite strong analyst support. The company shows concerning fundamentals with negative net income margins (-196.28%) and ROE (-48.24%), though revenue reached $647.44M in 2025. Recent strategic shift to data center services with $9.8B in contracted lease revenue through 2048 provides long-term visibility.
While analyst consensus remains strongly bullish (94.74% buy ratings) with $31.64 price target, execution risks persist given consecutive earnings misses and negative cash flow. The AI infrastructure pivot offers growth potential but requires careful monitoring of profitability improvements and Bitcoin market volatility exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →